Controversy has erupted over a pharmaceutical company’s plan to raise the cost of a drug used to treat HIV from US $13.50 to $750 overnight. The drug, called Daraprim, was acquired in August by Turing Pharmaceuticals, a start-up run by a former hedge fund manager. Turing immediately raised the price to $750 a tablet from […]